Substance use, mental health and weight‐related behaviours during the COVID ‐19 pandemic in people with obesity
| Autor: | Sachin Kukreja, Luyu Xie, Jaime P. Almandoz, Benjamin Schneider, Jeffrey N. Schellinger, Sarah E. Messiah, Ashley Ofori, Nora Bismar, M. Sunil Mathew, Denise C. Vidot |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
obesity medicine.medical_specialty Substance-Related Disorders 030309 nutrition & dietetics Endocrinology Diabetes and Metabolism Health Behavior Population substance use Bariatric Surgery 030209 endocrinology & metabolism Body Mass Index 03 medical and health sciences 0302 clinical medicine COVID‐19 Original Research Articles medicine Obesity medicine Humans Original Research Article education Psychiatry Retrospective Studies 0303 health sciences education.field_of_study SARS-CoV-2 business.industry Medical record COVID-19 Feeding Behavior Odds ratio Middle Aged medicine.disease Obesity Mental health United States Mental Health Quarantine ethnicity Anxiety Female medicine.symptom business Body mass index |
| Zdroj: | Clinical Obesity |
| ISSN: | 1758-8111 1758-8103 |
| Popis: | Summary Studies have shown the negative impact of COVID‐19 lockdown orders on mental health and substance use in the general population. The aim of this study was to examine the impact of the COVID‐19 pandemic onsubstance use, mental health and weight‐related behaviors in a sample of adults with obesity after lockdown orders were lifted (June‐September 2020). A retrospective medical chart review identified patients with obesity from one university‐based obesity medicine clinic, and two metabolic and bariatric surgery (MBS) practices. Patients who completed an online survey from June 1, 2020 to September 30, 2020 were included. The primary outcome measure was substance use (various drugs, alcohol, tobacco). Substance use and mental health survey questions were based on standardized, validated instruments. A total of 589 patients (83.3% female, mean age 53.6 years [SD 12.8], mean BMI 35.4 [SD 9.1], 54.5% Non‐Hispanic white, 22.3% post‐MBS) were included. Seventeen patients (2.9%) tested positive for SARS‐CoV‐2 and 13.5% reported symptoms. Nearly half (48.4%) of the sample reported recreational substance use and 9.8% reported increased use since the start of the pandemic. There was substantial drug use reported (24.3% opioids, 9.5% sedative/tranquilizers, 3.6% marijuana, and 1% stimulants). Patients who reported stockpiling food more (adjusted Odds Ratio [aOR] 1.50, 95% CI 1.03‐2.18), healthy eating more challenging (aOR 1.47, 95% CI 1.01‐2.16), difficulty falling asleep (aOR 1.64, 95% CI 1.14‐2.34), and anxiety (aOR 1.47, 95% CI 1.01‐2.14) were more likely to report substance use versus non‐users. Results here show that the COVID‐19 pandemic is having a deleterious impact on substance use, mental health and weight‐related health behaviors in people with obesity regardless of infection status. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text